Independent blood centers from coast to coast are facing critical shortages, according to information compiled by their trade association. Of the 59 organizations in America’s
COVID-19 testing facility based at BioBridge Global receives $1 million boost Getting the Community Labs COVID-19 testing program up and running in just three months is a
Beginning Monday, October 5, the City of San Antonio’s no cost testing sites will have a soft launch to expand testing to asymptomatic individuals. The
Despite 150 years of research, major roadblocks keep scientific ‘Holy Grail’ out of reach.
New Emergency Use Authorization could make COVID-19 therapy more readily available to coronavirus patients The Food and Drug Administration has changed the status of COVID-19
Convalescent plasma, first discovered in the 19th century, authorized for use in fight against coronavirus A doctor’s reaction to a potential epidemic almost 90 years
The COVID-19 antibody testing on your blood donation with the South Texas Blood & Tissue Center is a test looking for your body’s response to
Biomanufacturing facility begins production of large-scale adult stem cells GenCure’s Biomanufacturing facility at the VelocityTX Innovation Center, located at the Merchant’s Ice Complex in San Antonio, is
With baseline studies close to completion, the GenCure Biomanufacturing facility at the VelocityTX innovation center is on track to be fully operational in the first quarter of
BioBridge Global has added two new members to its Regenerative Medicine Advisory Board, a group composed of industry leaders with a wide range of scientific,
In a breakthrough for the regenerative medicine industry, GenCure announced today that its biomanufacturing services team has successfully completed production runs expanding and harvesting human mesenchymal stem